Abvance Secures Seed Funding for Safer Diabetes Management | StartUp Health Insights: Week of Jul 1, 2025
Abvance Therapeutics – a member of the StartUp Health community – is developing practical, predictable glucagon analogs and co-formulations designed to integrate seamlessly into modern treatment regimens for people with diabetes. Other funding this week included massive rounds for Abridge, ForSight Robotics, and Neuron23.
Written by Nicole Kinsey
Abvance Therapeutics, a member of the T1D Moonshot Community, closed its initial seed financing led by Zubi Capital. The biotechnology company develops next-generation glucagon analogs and therapies to prevent hypoglycemia and improve glucose management. <source>
Other global health innovation funding recently reported included:
Abridge, a Pittsburgh, PA-based startup that has developed AI-centered solutions for automating doctors’ notetaking, raised $300M led by Andreessen Horowitz, with participation from Khosla Ventures. <source>
ForSight Robotics, a Yokneam Illit, Israel-based ophthalmic robotic surgery company, raised $125M led by Eclipse, with participation from Dr. Fred Moll, the Adani Group, Reiya Ventures, and other investors. <source>
Neuron23, a San Francisco, CA-based biotech company focused on developing precision medicines for neurological and immunological diseases via an ML- and AI-driven drug discovery and biomarker platform, raised $96.5M led by an undisclosed healthcare investor, with participation from Westlake Village BioPartners, SoftBank Vision Fund 2, Redmile Group, Blue Owl, Kleiner Perkins, HBM Healthcare Investments (Cayman) Ltd., and Acorn Bioventures. <source>
Ubie, a Tokyo, Japan- and New York, NY-based AI-driven and medically-vetted healthcare prediction platform that guides patients to the care they need, raised around $65M from Google, Japan Post Capital, NTT Docomo, Seven-Eleven Japan Co., Japan Finance Corporation, and The Shoko Chukin Bank. <source>
Mandolin, a San Francisco, CA-based AI automation platform for specialty drug access, raised $40M from Greylock Partners, SignalFire, Maverick, SV Angel, and individual investors. <source>
EnsoData, a Madison, WI-based company providing AI-powered sleep diagnostics, raised $20M led by Questa Capital. <source>
SuperDial, a developer of voice AI agents to automate high-friction phone calls for healthcare organizations, raised $15M led by SignalFire, with participation from Slow Ventures, Box Group, and Scrub Capital. <source>
Elfie, a New York, NY-based digital health app that rewards people for taking care of their health, raised $12M led by White Star Capital, with participation from LifeX Ventures, Integra Partners, FEBE Ventures, and Hustle Fund. <source>
Handspring, a New York, NY-based mental health provider focused on youth, young adults, and their families through high-quality virtual therapy, raised $12M led by Cobalt Ventures, with participation from NextView Ventures, nvp capital, 25madison, Arkitekt Ventures, VamosVentures, Hyde Park Angels (HPA), Cornucopian Capital, and other investors. <source>
InfinityBio, a Baltimore, MA-based biotech company pioneering technologies to map immune responses at scale, raised $8M led by Illumina Ventures, with participation from PTX Capital, Blackbird BioVentures, and Propel Baltimore Fund. <source>
Lyrebird Health, a Melbourne, Australia-based AI-powered platform that helps transcribe medical notes from doctor-patient conversations, raised A$12M ($7.9M) led by Five V Capital and Octopus Ventures, with participation from Startmate. <source>
Empo Health, a San Bruno, CA-based developer of an at-home monitoring system to help prevent diabetic amputations and reduce healthcare costs for high-risk patients, raised $7M led by Story Ventures, with participation from VTC Ventures, Ulu Ventures, SeaX Ventures, Arben Ventures, and Gaingels. <source>
NiaHealth, a Toronto, ON, Canada-based health tech startup providing end-to-end proactive care, raised $5.75M led Golden Ventures, with participation from Kyle Braatz, Satish Kanwar and Arati Sharma, Jonathan Ehrlich, Zach Coelius, The51 women-focused venture fund, Jason Smith, Kathy Butler, Boris Wertz, ScaleGood Fund, Garage Capital, and Ivan Yuen. <source>
Juniper Genomics, a Toronto, ON, Canada-based health tech company focused on improving the standard of care in IVF, raised $4.6M led by Company Ventures, with participation from Innospark Ventures, MBX Capital, Amboy Street Ventures, Dria Ventures, and Blue Collective. <source>
NexusMD, a Melbourne, Australia-based startup developing AI agents to help hospital staff automate and save time on administrative tasks, raised A$6.3M ($4.1M) from Square Peg. <source>
CalmWave, a Seattle health tech startup working to eliminate unnecessary alarms attached to patients in hospital intensive care units, raised $4.4M led by Third Prime, Bonfire Ventures, Catalyst by Wellstar, and Silver Circle. <source>
LogicFlo, a Boston, MA-based provider of an AI agent platform for life sciences organizations across the pharmaceutical, biotech, and medtech industries, raised $2.7M led by Lightspeed, with participation from other investors. <source>
Nephrolytics, a Chubbuck, ID-based provider of an AI-powered clinical intelligence platform for kidney care, raised $2.5M from undisclosed investors. <source>
Vellum Health, an Austin, TX-based provider of a mobile healthcare platform, raised an undisclosed amount led by FCA Venture Partners, with participation from Green Park & Golf Ventures and angel investors. <source>
Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
Call for Innovation
Are You Ready to Find Your Tribe?
We’re looking for founders and CEOs leading digital health, life science, or biotech companies that want to build a better network to change the world. Health Moonshot Communities are exclusive, mission-aligned networks of founders, CEOs, and partners collaborating to solve the biggest health challenges of our time.
Our communities include: Alzheimer’s Disease, Cardiometabolic Health, Food as Medicine, Mental & Behavorial Health, Type 1 Diabetes, and more.
If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today.
Follow us on LinkedIn for daily updates on Health Transformers.
